Hikma Pharmaceuticals Share Discussion Threads

[mrthomas] 21/10/2016 11:26

Sold out rather make a profit then see it turn into a loss may buy in again

[gertie2shoes] 21/10/2016 08:42

Any thoughts that this might be to do with the likelihood that Clinton is going to be president and will prevent price gouging by pharma on products. Suspect that HIKMA price is badly influenced. Whereas HIK are producing generics mostly I gther.

[mrthomas] 21/10/2016 03:10

Thinking of selling as from 50% gain to less than 10% not sure why this is the case all in less than 6/8 months

[r ball] 20/10/2016 21:13

Us legislation?

[r ball] 04/10/2016 07:59

Hope springs eternal.

[sandeep67] 09/9/2016 09:11

Someone explain how repeated multi million pound share purchases over last weeks have contributed to daily declines in s/p. I nolonger understand this part

[mrthomas] 05/9/2016 09:35

well not really sure what to make of this share was up 50% a few weeks ago now about 20% think that its still in FT 100 so that helps

[r ball] 01/9/2016 17:42

No. Boehringer potential and Luke warm product lanches

[sandeep67] 01/9/2016 12:58

3 directors spent millions on shares each yesterday. Looks like Institutions want in by dropping the price to encourage scared selling. Can't see why the share price is inversing against the huge guys

[mrthomas] 01/9/2016 12:05

This share is getting too up and down for me now thinking of selling just hope stays up n FT 100 other wise will g down even more

[r ball] 24/8/2016 07:24

well there you go. Naff results by share price up.

Got to be on target for £30 now.

[r ball] 23/8/2016 20:19

Tomorrow is another day?

[rrb] 07/8/2016 12:41

Problem is the management discloses very little and this is the third time they've messed up in a year. First they said their gout treatment was fine and two months later they warned on it. Then they said actually 2015 revenues for Roxane were
much lower than expected and so they got a massive discount on the purchase price. Now they are saying 2016 revenues from this generics business will miss.

Clearly a pattern here.....but if you want to take the risk then good luck. I'd rather in invest in a company that gives more discoloured and whose management know how to forecast.

[mrthomas] 06/8/2016 10:49

should still be in the FT100 so the good and as you said good recovery not sure what the fuss was about still I think a long term hold

[gucci] 05/8/2016 10:21

great recovery

[greenpastures2] 04/8/2016 08:46

Numis downgrade- target price about where it was yesterday.

[chrisgail] 04/8/2016 08:20

Steady, or, boring, to put it another way maybe exactly what might be good to be invested in over the next year or two. They are growing the business at a very steady rate, it remains a long term hold in any portfolio.

[mrthomas] 04/8/2016 08:19

seems you were right can't see what the problem is but that a big mark down

[rrb] 04/8/2016 07:02

Won't be boring today. This will question Roxane acquisition value again.

[r ball] 30/7/2016 06:15

Still boring

[r ball] 28/7/2016 14:15

Boring share.

[mrthomas] 26/7/2016 12:32

This just seems to be going up which is nice so assume that the take over going well and seems to have good news flow but of course some stage will go down question is when

[r ball] 22/7/2016 13:31

ah...the trend is your friend as they say...until it breaks.

[rrb] 22/7/2016 12:31

Fair enough. I read an article in the Motley Fool saying weak GBP benefits Hikma. It really doesn't, apart from the FX translation (as GBP drops, it looks cheaper in USD terms). Dangerous levels here - so much priced in and stock grinding higher on ever-decreasing volumes.